
The government says the expanded cap could cut medicine prices by up to 70%, as the Supreme Court seeks a broader explanation.
India has imposed a 30% trade-margin cap on 137 more cancer drugs, with the lower prices due to take effect next month. The move followed Supreme Court scrutiny of mark-ups on the medicines.
The Department of Pharmaceuticals said the measure is expected to reduce prices by up to 70% and save patients 2,500 crore rupees a year. A 30% cap already applied to 42 drugs.
The Supreme Court has also asked the government why the cap should apply only to cancer medicines and not all non-patented drugs. It gave the government until 27 October to respond.
This article was produced with the help of AI technology. Based on reporting by the outlets listed above.